Quinsam Monthly Update for March 2014

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED
STATES NEWS DISTRIBUTION


Quinsam Capital Corporation (CSE:QCA) ("Quinsam" or the "Company") today
announced the completion of three recent investments.


Quinsam participated in the recent new issue at $2.25/unit by Nuvo Research Inc.
("NRI"). NRI is a life science company that has both products on the market
generating significant revenue and cash flow and also an important new product
in advanced clinical trials. We think that each of these elements could easily
justify the price we paid for our investment. NRI's marketed products include
Pennsaid (a topical treatment for the signs and symptoms of osteoarthritis of
the knee), Pennsaid 2% (a topical treatment for the pain of osteoarthritis of
the knee), Pliaglis (a topical local anesthetic) and the heated
lidocaine/tetracaine patch (HLT Patch). 


We also purchased shares in Kane Biotech Inc. ("KNE"). Kane is developing a
suite of animal health products. The products are generally based on antibiofilm
and antimicrobial technology and partnership discussions are in progress. KNE is
also exploring technology applications outside of the veterinary market. 


Additionally, we purchased shares in TIO Networks Corp. (TSX VENTURE:TNC). Tio
Networks is a Canadian based payment processor with operations in North America
and the Caribbean. TNC recently closed the acquisition of Globex Financial
Services and reported earnings that included one month of Globex revenue
indicating much improved profitability and renewed organic growth.


Performance Update

Quinsam would also like to take this opportunity to update investors on the
Company's recent performance.


As at the end of March 2014, the unaudited total value of the Quinsam's cash and
equity investments was approximately $1.8 million, compared with a value of
$982,000 at the end of February 2014. The growth in the portfolio was due to the
completion of the previously announced private placement. Small cap markets
suffered some softness in the last part of March and overall investment
performance in March was modestly negative after a strong February. The losses
were more than offset by gains in the first few days of April.


Roger Dent stated, "We continue to be pleased with our overall investment
performance to date. While March was not a great month overall for small caps,
we attribute this to a normal correction after several strong months plus a
relative absence of news due to the annual earnings reporting cycle. We continue
to see the outlook as being very positive."


About Quinsam Capital Corporation 

Quinsam is a merchant bank based in Canada. Our merchant banking business may
encompass a range of activities including acquisitions, advisory services,
lending activities and portfolio investments. Quinsam invests its capital for
its own account in assets, companies or projects which we believe are
undervalued and where we see a viable plan for unlocking such value. We do not
invest on behalf of any third party and we do not offer investment advice. 


Generally, Quinsam does not believe that individual investments are material
reportable events. Quinsam chooses to announce certain investments once the
company is certain that it has finished buying its position because the Company
feels that this information helps investors in Quinsam understand its investment
decision making process. Generally, Quinsam does not announce the sale of
investments. 


This press release may contain forward-looking statements relating to
anticipated future events, results, circumstances, performance or expectations
that are not historical facts but instead represent our beliefs regarding future
events, which are inherently uncertain. Forward-looking statements can often,
but not always, be identified by forward-looking words such as "anticipate",
"believe", "continue", "expect", "goal", "plan", "intend", "estimate", "may",
"project", "predict", "potential", "target", and "will" or similar words
suggesting future outcomes, or other expectations, beliefs, plans, objectives,
assumptions, intentions or statements about future events or performance. 


By their nature, forward-looking statements require us to make assumptions which
include, among other things, that (i) Quinsam will have sufficient capital under
management to effect its business strategies, (ii) the business strategies will
produce the results intended by Quinsam, and (iii) the markets will react and
perform in a manner consistent with the business strategies. 


Forward-looking information involves known and unknown risks, uncertainties and
other factors that may cause actual results or events to differ materially from
those anticipated in such forward-looking information. The Company believes that
the expectations reflected in the forward-looking information are reasonable but
no assurance can be given that these expectations will prove to be correct. Some
of the risks and other factors that could cause actual results to differ
materially from those expressed in forward-looking information expressed in this
press release include, but are not limited to: market and general economic
conditions, interest rates, regulatory and statutory developments, the nature of
the Company's investments, the available opportunities and competition for
investments, the concentration of the Company's investments in certain
industries and sectors, reliance on key personnel, risks affecting the Company's
investments, management of the growth of the Company, and exchange rate
fluctuations. Readers are cautioned that the foregoing list of risks and factors
is not exhaustive. Although the Company has attempted to identify important
factors that could cause actual events or results to differ materially from
those described in forward-looking information, there may be other factors that
cause events or results to differ from those intended, anticipated or estimated.



The forward-looking information contained herein is provided as at the date of
the date of this press release, based upon the opinions and estimates of
management and information available to management as at the date of this press
release. The Company does not undertake and specifically disclaims any intention
or obligation to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise, unless required by
applicable law. Readers are cautioned not to place undue reliance on
forward-looking information contained in this press release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Quinsam Capital Corporation
John Lewis
Business Development
(416) 523-7086
john@quinsamcapital.com


Quinsam Capital Corporation
Eric Szustak
President
(905) 330-7948
eric@quinsamcapital.com


Quinsam Capital Corporation
Roger Dent
CEO
(647) 993 5475
roger@quinsamcapital.com
Quinsam Capital (CSE:QCA)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024